CONMED
CNMD
157 hedge funds and large institutions have $1.32B invested in CONMED in 2015 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 59 increasing their positions, 56 reducing their positions, and 20 closing their positions.
10% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 20
5% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 56
1% more funds holding
Funds holding: 156 → 157 (+1)
17% less capital invested
Capital invested by funds: $1.59B → $1.32B (-$274M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
37% less call options, than puts
Call options by funds: $282K | Put options by funds: $446K
Top Buyers
Top Sellers
CNMD Hedge Fund Activity: Q3 2015 in Review
157 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q3 2015, worth a combined $1.32B — down 17% from $1.59B a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new CNMD positions and 20 closed out — a net gain of 2 holders — while 59 added to existing stakes and 56 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $31.7M. The largest seller was William Blair & Company, exiting entirely with an estimated $22.6M sold.
- 157 institutional investors held CONMED (CNMD) as of Q3 2015, up from 156 in Q2 2015.
- Funds reported $1.32B of CONMED stock for Q3 2015, down 17% quarter-over-quarter.
- 22 funds opened new CONMED positions in Q3 2015 and 20 closed out, a net change of +2 holders.
- The largest CONMED buyer in Q3 2015 was Fidelity Investments, an estimated $31.7M added.
- The largest CONMED seller in Q3 2015 was William Blair & Company, an estimated $22.6M sold.
Based on aggregated 13F filings for Q3 2015.